Sage Therapeutics (SAGE) Stock Forecast
AI forecast: SAGE
There is no current AI forecast for this stock.
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock PremiumAbout This Company
Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The company offers therapies for schizophrenia, clinical depression, pain, and traumatic brain injury. Sage Therapeutics operates in the United States.